INCREASED COSTS DUE TO MYOCARDIAL INFARCTION (MI) IN FRANCE- AN OBSERVATIONAL ANALYSIS USING A CLAIMS DATABASE

Author(s)

Blin P1, Philippe F2, Laurendeau C3, Bouee S4, Gourmelen J5, Levy Bachelot L6, Leproust S6, Steg PG7
1INSERM CIC1401, ADERA, Bordeaux University, Bordeaux, France, 2Département de Pathologie Cardiaque, Paris, France, 3Cemka-Eval, Bourg La Reine, France, 4CEMKA, Bourg La Reine, France, 5INSERM UMS 011, Villejuif, France, 6MSD France, COURBEVOIE, France, 7Département de Cardiologie, Paris, France

OBJECTIVES: Estimate the incremental annual cost after a myocardial infarction (MI) METHODS: A French representative cohort of patients who had a MI in France between 2007 and 2011 was extracted from a claim database of 600,000 patients. Costs were calculated from a community perspective, restricted to direct costs and from a health insurance scheme perspective. This analysis was performed on subjects still alive one year after MI RESULTS: A total of 1,920 subjects were identified with an index MI: 2/3 were males, mean age=67.2 y, 20.6% had diabetes, 37.6% hypercholesterolemia and 82.4% hypertension. Among the 1,920 subjects, 346 died in the first year and 3 were lost to follow-up: the cost was performed on 1,571 patients. The annual cost from a health insurance scheme perspective approximately tripled as it increased from €3,940 to €11,914 after a MI: Hospital cost increased from €1,616 before the index MI to €6,470 after hospitalization (the cost of the index hospitalization is excluded from the cost); Average community-based care costs increased from €2,323 before the index MI to €5,443 after: Travel costs increased from 127€ to 573€; Fees related to physician consultations increased from 589€ to 1,676€ (annual mean number consultations with a general practitioner and a specialist increased from 7.6 to 10.9 and from 5.4 to 10 respectively); Fees related to laboratory tests increased from 139€ to 408€; Cost of medicinal products increased from 1,105€ to 2,283€; Cost of medical non physician health professionals increased from 380€ to 534€. It should be noted that the mean cost related to the index MI hospitalization was €5,876 . The evolution of the costs from a community perspective was similar. CONCLUSIONS: The economic impact of recurrent cardiovascular events is substantial since healthcare consumption costs almost tripled after the index MI event

Conference/Value in Health Info

2015-11, ISPOR Europe 2015, Milan, Italy

Value in Health, Vol. 18, No. 7 (November 2015)

Code

PCV72

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×